
News|Articles|July 1, 2006
Pipeline Preview (July 2006)
Approvable designations
Advertisement
Approvable designations
Fast-track designations
Priority review
Non-approvable designations
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Neffy’s first year: $72.2m in sales, 10,000 schools and broadening payer access
2
Brukinsa/rituximab cuts progression risk 43% in mantle cell lymphoma
3
Key Takeaways, Study Limitations, and the Broader Implications of CROWN for Patients, Providers, and Payers
4
































